408 results
Page 16 of 21
6-K
0erby519e131br sokdh
8 Aug 11
Teva Receives Fda Acceptance of Its New Drug Application for BDP Nasal Hfa for the Treatment of Allergic Rhinitis
12:00am
6-K
4qrqek e2ca
2 Aug 11
Results of Phase III Bravo Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment
12:00am
6-K
2j6pq
2 Aug 11
Teva Receives European Marketing Authorization for Zoely??? Oral Contraceptive
12:00am
6-K
ghlzyd slfd1t42jw
2 Aug 11
Teva Announces Launch of Camrese??? the Authorized Generic of Seasonique?
12:00am
6-K
sqs lby4zlp7pp6hi
1 Aug 11
Teva Announces Launch of Camrese??? the Authorized Generic of Seasonique?
12:00am
6-K
14ybaz7b
28 Jul 11
Current report (foreign)
12:00am
6-K
EX-99.1
09eh446j2
27 Jul 11
Teva Reports Second Quarter 2011 Results
12:00am
6-K
fxdqkvrh weja58wbc
13 Jul 11
Teva Comments on Supreme Court Decision
12:00am
6-K
wb9tteod64dgpx
27 Jun 11
Teva Comments on Supreme Court Decision
12:00am
6-K
wfn1r q0yd5nw21ie3t
21 Jun 11
Teva and Pfizer Settle Generic Neurontin? Litigation
12:00am
6-K
819 cn3r2xytjq
21 Jun 11
Teva Announces Successful Results of Phase III Study of Its Long-acting G CSF Product (Lipegfilgrastim) In Breast Cancer Patients
12:00am
6-K
6vphdluz
14 Jun 11
Teva and Cephalon Receive FTC Request for Additional Information
12:00am
6-K
om1n6z
13 Jun 11
Teva Signs $4 Billion Syndicated Credit Facilities
12:00am
6-K
9jxh0q6vt u0xqb5n
2 Jun 11
Teva Announces Launch of Generic Aricept? Tablets In the United States
12:00am
6-K
mo09jpg86 ssw
2 Jun 11
Teva Completes Enrollment In Phase III Multiple Sclerosis Trial Evaluating Glatiramer Acetate Three Times Weekly
12:00am
6-K
0mjsp 1nd
31 May 11
Teva Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-induced Neutropenia In Breast Cancer Patients
12:00am
6-K
9oy65yai1m37s9
31 May 11
Teva Announces Approval of Generic Combivir Tablets: Launch Expected In Fourth Quarter 2011
12:00am
6-K
7ere2zu2qhn8o
19 May 11
Teva and Oncogenex to Present Data on Custirsen In Prostate Cancer at the 2011 Asco Annual Meeting
12:00am
6-K
o5pe93rixb v8t
17 May 11
Teva to Acquire Taiyo
12:00am
6-K
q2a7oa3ke0gco9jh8
17 May 11
Teva and Curetech Announce Positive Phase II Data from CT-011, an Investigational Antibody In Diffuse Large B Cell Lymphoma
12:00am